Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Molecular Therapy 24,
1003 (May 2016). doi:10.1038/mt.2015.227

Authors: Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, Cornelia Keller, Martin Osranek, Ute Lässing, Gunther Spohn, Patrik Maurer, Philipp Müller, Gary T Jennings, Joerg Willers, Philippe Saudan, Marc Y Donath & Martin F Bachmann

Source: Molecular Therapy - May 19, 2016 Category: Genetics & Stem Cells Authors: Claudia Cavelti-WederKatharina TimperEleonora SeeligCornelia KellerMartin OsranekUte LässingGunther SpohnPatrik MaurerPhilipp MüllerGary T JenningsJoerg WillersPhilippe SaudanMarc Y DonathMartin F Bachmann Source Type: research